These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9001901)

  • 1. Leprosy disabilities: magnitude of the problem.
    Indian J Lepr; 1996; 68(4):335-44. PubMed ID: 9001901
    [No Abstract]   [Full Text] [Related]  

  • 2. Reflections on the new WHO leprosy indicator: the rate of new cases with grade 2 disabilities per 100,000 population per year.
    Declercq E
    Lepr Rev; 2011 Mar; 82(1):3-5. PubMed ID: 21644466
    [No Abstract]   [Full Text] [Related]  

  • 3. Remaining challenges towards the elimination of leprosy. Leprosy Elimination Project World Health Organization.
    Leprosy Elimination Project, World Health Oranization
    Indian J Lepr; 2000; 72(1):33-45. PubMed ID: 10935185
    [No Abstract]   [Full Text] [Related]  

  • 4. Future prevalence of WHO grade 2 impairment in relation to incidence trends in leprosy: an exploration.
    Meima A; van Veen NH; Richardus JH
    Trop Med Int Health; 2008 Feb; 13(2):241-6. PubMed ID: 18304271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical correction of deformities and disabilities in leprosy patients.
    Virmond M; Pereira H da R
    Indian J Lepr; 2000; 72(3):401-12. PubMed ID: 11105280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disabilities among rural leprosy patients in Myanmar.
    Htoon MT; Win Z
    Int J Lepr Other Mycobact Dis; 1994 Mar; 62(1):126-30. PubMed ID: 8189078
    [No Abstract]   [Full Text] [Related]  

  • 7. Terminology in leprosy rehabilitation and guidelines for nerve function assessment.
    Brandsma JW
    Trop Geogr Med; 1994; 46(2):88-92. PubMed ID: 8079397
    [No Abstract]   [Full Text] [Related]  

  • 8. WHO Expert Committee on Leprosy.
    World Health Organ Tech Rep Ser; 1998; 874():1-43. PubMed ID: 9627517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of disabilities among multi-bacillary cases after initiation of multidrug therapy and factors associated with the risk of developing disabilities.
    Selvaraj G; Prabakar N; Muliyil J; Martin G
    Indian J Lepr; 1998; 70 Suppl():11S-16S. PubMed ID: 10992862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bangkok Workshop on Leprosy Research. Research needs related to disabilities and rehabilitation.
    Smith WC; van Brakel WH
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S52-4; discussion S54-5. PubMed ID: 9030125
    [No Abstract]   [Full Text] [Related]  

  • 11. Global trends in disability rehabilitation and their implications for leprosy programmes.
    Thomas M; Thomas MJ
    Lepr Rev; 2008 Mar; 79(1):10-6. PubMed ID: 18540233
    [No Abstract]   [Full Text] [Related]  

  • 12. Aspects of rehabilitation in leprosy.
    Gilbody JS
    Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):608-40. PubMed ID: 1299715
    [No Abstract]   [Full Text] [Related]  

  • 13. The impact of leprosy control on the transmission of M. leprae: is elimination being attained?
    Richardus JH; Habbema JD
    Lepr Rev; 2007 Dec; 78(4):330-7. PubMed ID: 18309706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The program for the elimination of leprosy: ambitious challenges, novel approaches, issues in doubt].
    Lechat F
    Bull Mem Acad R Med Belg; 1999; 154(3-4):201-6; discussion 206-7. PubMed ID: 10687248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention-of-impairment-and-disabilities activities in leprosy after integration: role for physical medicine and rehabilitation personnel.
    Malaviya GN
    Indian J Lepr; 2006; 78(4):347-57. PubMed ID: 17402347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological aspects of ocular morbidity in leprosy-affected persons.
    Sundar Rao PS; Daniel E; Kurian N; Gayathri KJ
    Indian J Lepr; 1998; 70(1):115-22. PubMed ID: 9598413
    [No Abstract]   [Full Text] [Related]  

  • 17. Classification of disabilities resulting from leprosy, for use in control projects.
    Bull World Health Organ; 1969 Apr; 40(4):609-12. PubMed ID: 5306725
    [No Abstract]   [Full Text] [Related]  

  • 18. [The International Classification of Functioning, Disability and Health].
    Seidel M
    Nervenarzt; 2005 Jan; 76(1):79-90; quiz 91-2. PubMed ID: 15624112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capture-recapture method to assess the prevalence of disabled leprosy patients.
    Van den Broek J; Van Jaarsveld T; de Rijk A; Samson K; Patrobas P
    Lepr Rev; 2001 Sep; 72(3):292-301. PubMed ID: 11715275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leprosy: too complex a disease for a simple elimination paradigm.
    Lockwood DN; Suneetha S
    Bull World Health Organ; 2005 Mar; 83(3):230-5. PubMed ID: 15798849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.